Jayson Rieger, CEO and President at Verrica Pharmaceuticals Inc. (VRCA), bought 25,000 shares at $5.06 ($126K) on 2026-08-14, disclosed to the SEC on 2026-08-18.
CEO Jayson Rieger purchased $101,200 worth of stock at $5.06 per share, marking the largest insider purchase in the company's history. This significant buyback by leadership suggests confidence in the company's recent operational progress and cash runway extension.
The stock is trading near the bottom of its 52-week range, currently 49.09% below the high of $9.82 and down 16.94% over the last 90 days. The recent price action has been bearish, with a 9.75% decline over the past 30 days.
1) Q2 2026 earnings on August 6, 2026, where the company reported a +14.29% earnings surprise and +1.77% revenue surprise. 2) Management announced a credit facility that extends cash runway into 2028, as detailed in the Q2 earnings call on August 7, 2026. 3) The CEO's purchase is the largest insider buy ever recorded, signaling a rare reversal in sentiment.
The stock is highly volatile with a beta of 1.493 and currently trades at a forward P/E of -3.18, indicating significant losses are expected by analysts. Additionally, the company has a short interest of 3.26% of the float, which could exacerbate price volatility if the stock rallies.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.06 | 20,000 | $101K | 80.5% |
| 2 | $4.91 | 5,000 | $25K | 19.5% |
| Total | $5.03 avg | 25,000 | $126K | 100% |